NRX Pharmaceuticals
Price & Volume
Stats
See moreOpen | $2.12 |
Previous Close | $2.11 |
Day Range | $2.09-$2.31 |
52W Range | $1.15-$6.01 |
Market Cap | $61.8M |
Shares Short | 860,796 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.21 |
News
See moreYahoo Finance • 2 days ago
NRx Pharmaceuticals outlines rapid clinic expansion and targets 6 or more locations by year-end 2025 amid new depression treatment advances
Yahoo Finance • 2 days ago
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 days ago
Here are the major earnings before the open Monday
Yahoo Finance • 4 days ago
Pre-Market Earnings Report for November 17, 2025 : HTHT, ARMK, YMM, JJSF, JKS, CRGO, ARBE, NRXP, IGC, VRME
About
CEO | Dr. Jonathan C. Javitt M.D., M.P.H. |
Address | 1201 Orange Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
